Kristen Hege
VP Clinical Research, CELL GENESYS INC.
Companies
- Adaptimmune (United Kingdom)Board member Nov 1, 2023 to now1
- Mersana Therapeutics (United States)Board member Jun 27, 2017 to now2
- LENZ Therapeutics, Inc.Board member Jun 24, 2021 to Jul 21, 20233
- Arcus BiosciencesBoard member Oct 22, 2018 to Jun 10, 20194
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Mersana Therapeutics (United States)0 shares5Jan 6, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 6, 2026U 578 shares of Mersana Therapeutics (United States)5
- Jun 8, 2023Granted 14,467 shares of Mersana Therapeutics (United States)6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARArcus Biosciences, Board member
- 5
- 6SEC EDGARForm 4 filed Jun 12, 2023